Best of Pharmaceuticals Data Provider: 22 Cataloged

The 10 Best Pharmaceuticals Datasets in 2026

10 Pharmaceuticals Data Provider: 22 Cataloged picks, ranked on what's inside: field richness, coverage depth, fit for the job. openFDA Drug APIs leads.

  • 10ranked picks
  • 11documented fields on stage
  • 0/9with mapped coverage

API, files, or your warehouse. Daily, weekly, or hourly.

Every dataset here carries a 0–10 score built on documented fields, and the ranking follows those scores. When records tie, coverage breaks it: more geography, deeper history, finer granularity. Cadence isn't a scoring axis — it's a delivery setting. Delivered daily, weekly, or hourly, your call.

  1. 1 10/10
    Pharmaceuticals Data Provider: 22 Cataloged

    openFDA Drug APIs

  2. 2 10/10
    Pharmaceuticals Data Provider: 22 Cataloged

    EMA Medicines Catalogue

    name_of_medicine · ema_product_number

  3. 3 9/10
    Pharmaceuticals Data Provider: 22 Cataloged

    ChEMBL Web Services API

  4. 4 9/10
    Pharmaceuticals Data Provider: 22 Cataloged

    PubChem PUG REST API

  5. 5 9/10
    Pharmaceuticals Data Provider: 22 Cataloged

    RxNorm / RxNav Browser and APIs

    rxcui · name · synonym …+6 more

  6. 6 9/10
    Pharmaceuticals Data Provider: 22 Cataloged

    EMA Download Medicine Data Tables

  7. 7 8/10
    Pharmaceuticals Data Provider: 22 Cataloged

    WHO ATC/DDD Index

  8. 8 8/10
    Pharmaceuticals Data Provider: 22 Cataloged

    KEGG DRUG Database

  9. 9 KEGG REST API
  10. 10 7/10
    Pharmaceuticals Data Provider: 22 Cataloged

    DrugBank Open Data

Also worth a berth

Frequently asked questions

How do I normalise messy drug names in prescribing or claims data?

RxNorm / RxNav: ~120k concepts per release resolving ingredient, branded, clinical-drug and pack levels to stable RXCUI identities with associated NDCs, strengths, dose forms and class placement. Layer the WHO ATC/DDD Index on top for an international classification, and use DrugBank's synonym vocabulary to reconcile identifiers across markets.

How far back does the historical coverage go?

Deeper than most buyers expect: openFDA adverse-event reports accumulate from Q3 2004, EMA product histories reach the mid-1990s centralised procedure era, ChEMBL aggregates literature through release 37 with decades of published screening behind it, and some Data.gov-indexed agency series extend back generations.

What is the fastest way to evaluate one of these records?

Request a scoped sample. Name the indication, target class, market or product list and the cut arrives as typed rows sized to your question - a filtered slice of the same fields described above - so the test runs inside your own pipeline. Delivery is daily, weekly, or hourly, your call, and no commitment precedes the sample.